Constantijn J.M. Halkes

3.1k citations

60 papers · 1.2k indexed · h-index 20

Co-authors: Manuel Castro Cabezas J.H. Frederik Falkenburg D.W. Erkelens Erik W.A. Marijt Peter P.T. de Jaegere Marieke Griffioen Inge Jedema J.P.H. van Wijk
Topics: Hematopoietic Stem Cell Transplantation (27 papers)Acute Myeloid Leukemia Research (17 papers)T-cell and B-cell Immunology (16 papers)
Cited by: Hematology Immunology Endocrinology, Diabetes and Metabolism
Journals: Journal of Clinical Investigation Blood The Journal of Immunology
Partner nations: Netherlands Germany Italy

In The Last Decade

Constantijn J.M. Halkes

56 papers receiving 1.2k citations

Peers

Countries citing papers authored by Constantijn J.M. Halkes

Since Specialization

Citations

This map shows the geographic impact of Constantijn J.M. Halkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantijn J.M. Halkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantijn J.M. Halkes more than expected).

Fields of papers citing papers by Constantijn J.M. Halkes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constantijn J.M. Halkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantijn J.M. Halkes. The network helps show where Constantijn J.M. Halkes may publish in the future.

Co-authorship network of co-authors of Constantijn J.M. Halkes

This figure shows the co-authorship network connecting the top 25 collaborators of Constantijn J.M. Halkes. A scholar is included among the top collaborators of Constantijn J.M. Halkes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constantijn J.M. Halkes. Constantijn J.M. Halkes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation 2024 ·Frontiers in Immunology ·(unknown),Peter A. von dem Borne,Peter van Balen,Erik W.A. Marijt,Jennifer M.L. Tjon,(unknown),(unknown),Hendrik Veelken,J.H. Frederik Falkenburg,Constantijn J.M. Halkes,Liesbeth C. de Wreede	2
2	Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens 2024 ·Blood ·(unknown),Marian van de Meent,M. Willy Honders,Indu Khatri,Michel G.D. Kester,(unknown),(unknown),Arnoud H. de Ru,Cornelis A.M. van Bergen,Peter A. van Veelen,Peter A.C. ’t Hoen,Peter van Balen,Erik B. van den Akker,Hendrik Veelken,Constantijn J.M. Halkes,J.H. Frederik Falkenburg,Marieke Griffioen	6
3	A transcriptomic based deconvolution framework for assessing differentiation stages and drug responses of AML 2024 ·npj Precision Oncology ·Emin Onur Karakaslar,(unknown),Elena Sánchez‐López,Peter A. van Veelen,Mihaela Zlei,Jacques J. M. van Dongen,(unknown),Constantijn J.M. Halkes,Peter van Balen,Hendrik Veelken,Marcel Reinders,Marieke Griffioen,Erik B. van den Akker	5
4	Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients 2023 ·Annals of Hematology ·(unknown),(unknown),Peter A. von dem Borne,(unknown),(unknown),(unknown),(unknown),Peter van Balen,Erik W.A. Marijt,Hendrik Veelken,J.H. Frederik Falkenburg,(unknown),Constantijn J.M. Halkes	4
5	Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation 2021 ·Transplantation and Cellular Therapy ·(unknown),Mahmoud Aljurf,(unknown),Mansour Alfayez,Andrea Bacigalupo,Riad El Fakih,Hubert Schrezenmeier,Syed Osman Ahmed,Éliane Gluckman,(unknown),Britta Höchsmann,Constantijn J.M. Halkes,Josu de la Fuente,(unknown),Simone Cesaro,Jakob Passweg,Carlo Dufour,Antonio M. Risitano,John F. DiPersio,Ibraheem Motabi	12
6	Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT) 2020 ·Bone Marrow Transplantation ·Ghada Elgohary,Riad El Fakih,(unknown),Antonio M. Risitano,Judith Marsh,Hubert Schrezenmeier,Éliane Gluckman,Britta Höchsmann,Filomena Pierri,Constantijn J.M. Halkes,Hazzaa Alzahrani,Josu de la Fuente,Simone Cesaro,Ali Alahmari,Syed Osman Ahmed,(unknown),Carlo Dufour,Andrea Bacigalupo,Mahmoud Aljurf	40
7	Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study 2019 ·Leukemia ·(unknown),Peter van Balen,Lothar Germeroth,Lois Hageman,(unknown),(unknown),(unknown),Ellis van Liempt,Jaap Jan Zwaginga,Liesbeth C. de Wreede,Pauline Meij,Ann C.T.M. Vossen,Sophia Danhof,Hermann Einsele,(unknown),Hendrik Veelken,Constantijn J.M. Halkes,Inge Jedema,J.H. Frederik Falkenburg	19
8	Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft 2019 ·Transplant Immunology ·Floris C. Loeff,(unknown),Dirk Jan A. R. Moes,(unknown),Peter A. von dem Borne,Hendrik Veelken,J.H. Frederik Falkenburg,Inge Jedema,Constantijn J.M. Halkes	8
9	Relapse of Aplastic Anemia with Majority Donor Chimerism (Donor-Type Aplasia) Occurring Late after Bone Marrow Transplantation 2019 ·Biology of Blood and Marrow Transplantation ·Abigail Shaw,Jakob Passweg,Josu de la Fuente,Rajinder Bajwa,Jerry Stein,(unknown),Constantijn J.M. Halkes,Alice Norton,Michelle Cummins,John Moppett,(unknown),Colin G. Steward	9
10	Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype 2018 ·Haematologica ·Frédéric Baron,Marian Stevens‐Kroef,Michal Kiciński,Giovanna Meloni,Petra Muus,Jean‐Pierre Marie,Constantijn J.M. Halkes,Xavier Thomas,Radovan Vrḫovac,Francesco Albano,François Lefrère,Simona Sica,Marco Mancini,Adriano Venditti,Anne Hagemeijer,Joop H. Jansen,Sergio Amadori,Théo de Witte,R. Willemze,Stefan Suciu	7
11	CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity 2018 ·Transplant Immunology ·Pim L. J. van der Heiden,(unknown),(unknown),Marian van de Meent,(unknown),Liesbeth C. de Wreede,Constantijn J.M. Halkes,J.H. Frederik Falkenburg,Erik W.A. Marijt,Inge Jedema	6
12	CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II 2018 ·Frontiers in Immunology ·Peter van Balen,Cornelis A.M. van Bergen,Simone A.P. van Luxemburg-Heijs,(unknown),(unknown),(unknown),Constantijn J.M. Halkes,Jaap Jan Zwaginga,Marieke Griffioen,Inge Jedema,J.H. Frederik Falkenburg	27
13	Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion 2016 ·Haematologica ·(unknown),Liesbeth C. de Wreede,Constantijn J.M. Halkes,Peter A. von dem Borne,Sabina Kersting,Erik W.A. Marijt,Hendrik Veelken,Hein Putter,Johannes Schetelig,J.H. Frederik Falkenburg	30
14	Effectivity of a strategy in elderly AML patients to reach allogeneic stem cell transplantation using intensive chemotherapy: Long-term survival is dependent on complete remission after first induction therapy 2016 ·Leukemia Research ·Peter A. von dem Borne,Liesbeth C. de Wreede,Constantijn J.M. Halkes,Erik W.A. Marijt,JH Falkenburg,Hendrik Veelken	13
15	Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013) 2015 ·Annals of Hematology ·Théo de Witte,Stefan Suciu,Liv Meert,Constantijn J.M. Halkes,Dominik Selleslag,Dominique Bron,Sergio Amadori,Roel Willemze,Petra Muus,Frédéric Baron	10
16	Patient HLA-DP–Specific CD4+ T Cells from HLA-DPB1–Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or Absence of Graft-versus-Host Disease 2012 ·Biology of Blood and Marrow Transplantation ·Caroline E. Rutten,Simone A.P. van Luxemburg-Heijs,Constantijn J.M. Halkes,Cornelis A.M. van Bergen,Erik W.A. Marijt,Machteld Oudshoorn,Marieke Griffioen,J.H. Frederik Falkenburg	46
17	Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines 2012 ·Journal of Immunotherapy ·Pauline Meij,Inge Jedema,Maarten L. Zandvliet,Pim L. J. van der Heiden,Marian van de Meent,(unknown),Ellis van Liempt,(unknown),Simone Kruithof,(unknown),Erik W.A. Marijt,Peter A. von dem Borne,Arjan C. Lankester,Constantijn J.M. Halkes,J.H. Frederik Falkenburg	46
18	The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis 2011 ·The Journal of Infectious Diseases ·Louis Yi Ann Chai,Mark de Boer,Walter J. F. M. van der Velden,Theo S. Plantinga,Annemiek B. van Spriel,Cor Jacobs,Constantijn J.M. Halkes,Alieke G. Vonk,Nicole M. A. Blijlevens,Jaap T. van Dissel,Peter Donnelly,Bart Jan Kullberg,Johan Maertens,Mihai G. Netea	88
19	Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis 2004 ·Atherosclerosis ·J.P.H. van Wijk,(unknown),Arie van Tol,Constantijn J.M. Halkes,Peter P.T. de Jaegere,H. W. M. Plokker,Yvonne J.M. van der Helm,Manuel Castro Cabezas	20
20	Fasting and daylong triglycerides in obesity with and without type 2 diabetes 2003 ·Metabolism ·J.P.H. van Wijk,Constantijn J.M. Halkes,D.W. Erkelens,Manuel Castro Cabezas	52

About Constantijn J.M. Halkes

Constantijn J.M. Halkes is a scholar working on Hematology, Immunology and Endocrinology, Diabetes and Metabolism, having authored 60 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (17 papers) and T-cell and B-cell Immunology (16 papers). The work is most often cited by research in Hematology (418 citations), Immunology (398 citations) and Endocrinology, Diabetes and Metabolism (184 citations). Constantijn J.M. Halkes has collaborated with scholars based in Netherlands, Germany and Italy. Frequent co-authors include Manuel Castro Cabezas, J.H. Frederik Falkenburg, D.W. Erkelens, Erik W.A. Marijt, Peter P.T. de Jaegere, Marieke Griffioen, Inge Jedema, J.P.H. van Wijk, Peter A. von dem Borne and Hendrik Veelken. Their work appears in journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact